Sarepta Therapeutics,, Inc. Common Stock
Symbol: SRPT (NASDAQ)
22.65
▼ (-3.02%) -0.705
Company Description:
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.
Key Stats
- Today's Open: $23.2
- Today's High: $23.667
- Today's Low: $22.316
- Today's Volume: 3.70M
- Yesterday Close: $23.35
- Yesterday High: $23.54
- Yesterday Low: $22.77
- Yesterday Volume: 2.87M
- Last Min Volume: 100
- Last Min High: $22.645
- Last Min Low: $22.645
- Last Min VWAP: $22.645
Company Profile
- Name: Sarepta Therapeutics,, Inc. Common Stock
- Website: https://www.sarepta.com
- Listed Date: 1997-06-04
- Location: CAMBRIDGE, MA
- Market Status: Active
- CIK Number: 0000873303
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $2.44B
- Round Lot: 100
- Outstanding Shares: 104.67M
- Asset Type: CS
RECENT FILINGS FOR SRPT
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-08 | SCHEDULE 13G/A | View |
| 2025-09-05 | 4 | View |
| 2025-09-05 | 4 | View |
| 2025-09-05 | 4 | View |
| 2025-09-05 | 4 | View |
| 2025-08-29 | 8-K | View |
| 2025-08-21 | 8-K | View |
| 2025-08-15 | SCHEDULE 13D/A | View |
| 2025-08-13 | 144 | View |
| 2025-08-13 | 8-K | View |
| 2025-08-13 | SCHEDULE 13G/A | View |
| 2025-08-06 | 4 | View |
| 2025-08-06 | 4 | View |
| 2025-08-06 | 4 | View |
| 2025-08-06 | S-8 | View |
| 2025-08-06 | 10-Q | View |
| 2025-08-04 | 4 | View |
| 2025-08-04 | 3 | View |
| 2025-07-25 | SCHEDULE 13G/A | View |
| 2025-07-25 | SCHEDULE 13G | View |
Latest News on SRPT